Vitamin Blue Price to Earning vs. Market Capitalization
VTMB Stock | USD 0.0001 0.00 0.00% |
For Vitamin Blue profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vitamin Blue to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vitamin Blue utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vitamin Blue's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vitamin Blue over time as well as its relative position and ranking within its peers.
Vitamin |
Vitamin Blue Market Capitalization vs. Price to Earning Fundamental Analysis
Vitamin Market Capitalization vs. Price to Earning
Vitamin Blue | = | null |
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Vitamin Blue |
| = | 14.1 K |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Vitamin Market Capitalization vs Competition
Vitamin Blue is rated first in market capitalization category among related companies. Market capitalization of Leisure industry is at this time estimated at about 404.03 Billion. Vitamin Blue adds roughly 14,101 in market capitalization claiming only tiny portion of all equities under Leisure industry.
Use Vitamin Blue in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vitamin Blue position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitamin Blue will appreciate offsetting losses from the drop in the long position's value.Vitamin Blue Pair Trading
Vitamin Blue Pair Trading Analysis
The ability to find closely correlated positions to Vitamin Blue could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vitamin Blue when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vitamin Blue - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vitamin Blue to buy it.
The correlation of Vitamin Blue is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vitamin Blue moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vitamin Blue moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vitamin Blue can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Vitamin Blue position
In addition to having Vitamin Blue in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Disruptive Technologies Thematic Idea Now
Disruptive Technologies
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 63 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
View All Next | Launch |
Check out World Market Map. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Vitamin Pink Sheet analysis
When running Vitamin Blue's price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
To fully project Vitamin Blue's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vitamin Blue at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vitamin Blue's income statement, its balance sheet, and the statement of cash flows.